Where does hepatocellular carcinoma (HCC) metastasize to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hepatocellular carcinoma (HCC) most commonly metastasizes to the lung, adrenal glands, peritoneum, and bone. According to the most recent guidelines, the major risk factors for the development of HCC are cirrhosis and chronic liver disease, regardless of etiology, and common sites of HCC metastasis include the lung, adrenal glands, peritoneum, and bone 1. The metastatic pattern of HCC is influenced by its vascular invasion tendency and the liver's unique dual blood supply from the hepatic artery and portal vein.

Metastatic Sites

  • The lung is a common site of metastasis due to venous drainage from the liver flowing directly to the lungs through the inferior vena cava.
  • The adrenal glands are also frequently affected, highlighting the importance of thorough imaging and staging.
  • The peritoneum and bone are other less frequent sites of metastasis, with bone metastases typically affecting the vertebrae, ribs, and pelvis, causing significant pain and potential pathological fractures.
  • Understanding these metastatic patterns is crucial for proper staging, treatment planning, and surveillance of HCC patients, as early detection of metastatic disease significantly impacts treatment options and prognosis, as noted in the guidelines 1.

Clinical Implications

The majority of patients diagnosed with HCC have advanced disease, and only a small percentage are eligible for potentially curative therapies 1. It is essential that all patients be evaluated by a multidisciplinary team prior to initiation of treatment, and careful patient selection for treatment and patient engagement are essential. The use of AFP and liver US as screening methods for HCC can aid in early detection and potentially improve outcomes 1.

From the Research

Metastasis of Hepatocellular Carcinoma (HCC)

Hepatocellular carcinoma (HCC) commonly metastasizes to various sites, including:

  • Lungs 2, 3, 4, 5
  • Lymph nodes 2, 3, 4, 5
  • Adrenal glands 2, 3
  • Bones 2, 3, 4, 6, 5
  • Skull 3
  • Portal vein 4
  • Portal lymph nodes 4
  • Intra-abdominal lymph nodes 4
  • Kidneys 6, 5
  • Nasopharynx 2
  • Orbit 4, 6
  • Maxillary sinus 6
  • Retrobulbar region 6
  • Soft tissue 5
  • Rib 5
  • Ovaries, as a rare site of extrahepatic metastasis 2
  • Brain, as a rare site of extrahepatic metastasis 2
  • Cardiac musculature, as a rare site of extrahepatic metastasis 2
  • Skeletal musculature, as a rare site of extrahepatic metastasis 2

Rare Sites of Metastasis

Some rare sites of metastasis have been reported, including:

  • Nasopharynx 2
  • Orbit 4, 6
  • Maxillary sinus 6
  • Retrobulbar region 6
  • Soft tissue 5
  • Rib 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Isolated nasopharyngeal metastasis from hepatocellular carcinoma.

International journal of surgery case reports, 2014

Research

Metastatic hepatocellular carcinoma.

Clinical oncology (Royal College of Radiologists (Great Britain)), 2003

Research

Hepatocellular Carcinoma: An Uncommon Metastasis in the Orbit.

Case reports in oncological medicine, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.